Eric Van
About Eric Van
Eric Van serves as the Director of Portfolio Strategy & Analytics at Kite Pharma, bringing extensive experience in the biotechnology sector, particularly in portfolio strategy and asset valuation. He previously worked for 25 years at Amgen and holds an MBA from Pepperdine University and a BS from Cornell University.
Work at Kite Pharma
Eric Van serves as the Director of Portfolio Strategy & Analytics at Kite Pharma, a position he has held since 2020. In this role, he focuses on portfolio strategy and asset valuation, leveraging his extensive experience in the biotechnology industry. His responsibilities include leading cross-functional programs and ensuring alignment with the company's strategic goals. Kite Pharma, based in Santa Monica, California, specializes in innovative cancer therapies, and Van's contributions are integral to the company's ongoing projects.
Previous Experience at Amgen
Prior to his current role, Eric Van worked at Amgen for 25 years, from 1995 to 2020. He held the position of Senior Project Manager in Commercialization and Program Management during his tenure. His extensive experience at Amgen provided him with a solid foundation in project management and strategic planning within the biotechnology sector. This background has equipped him with the skills necessary for effective portfolio management and analytics.
Education and Expertise
Eric Van earned his MBA from Pepperdine Graziadio Business School, where he studied from 1995 to 1999. He also holds a Bachelor of Science degree from Cornell University, which he completed from 1987 to 1991. His educational background supports his strong business acumen, essential for his role in portfolio strategy. Additionally, he possesses a PMP® certification and a Six Sigma Green Belt certification, highlighting his expertise in project management and process improvement.
Background
Eric Van has a robust background in the biotechnology industry, with a focus on portfolio strategy and asset valuation. His career spans over two decades, during which he has developed significant expertise in project management and cross-functional leadership. His experience at both Amgen and Kite Pharma reflects his commitment to advancing innovative solutions in the field of biotechnology.